Viewing Study NCT07059949


Ignite Creation Date: 2025-12-18 @ 9:15 AM
Ignite Modification Date: 2025-12-23 @ 9:19 PM
Study NCT ID: NCT07059949
Status:
Last Update Posted:
First Post:
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Short Course Radiotherapy Followed by CAPOX and Carrilizumab and Bevacizumab or Cetuximab for the Initial Treatment of Unresectable Metastatic Rectal Cancer
Sponsor:
Organization:

Study Modules

Design Module Eligibility Module Outcomes Module